<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0235958.ref045">
 <label>45</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>George</surname>
   <given-names>L</given-names>
  </name>. 
  <name>
   <surname>Melikian</surname>
  </name>, 
  <name>
   <surname>Soo-Yon</surname>
   <given-names>Rhee</given-names>
  </name>, 
  <name>
   <surname>Vici</surname>
   <given-names>Varghese</given-names>
  </name>, 
  <name>
   <surname>Danielle</surname>
   <given-names>Porter</given-names>
  </name>, 
  <name>
   <surname>Kirsten</surname>
   <given-names>White</given-names>
  </name>, 
  <name>
   <surname>Jonathan</surname>
   <given-names>Taylor</given-names>
  </name>
  <etal>et al</etal>
  <article-title>Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing</article-title>. 
  <source>J Antimicrob Chemother</source>
  <year>2014</year>; 
  <volume>69</volume>: 
  <fpage>12</fpage>â€“
  <lpage>20</lpage>
  <pub-id pub-id-type="doi">10.1093/jac/dkt316</pub-id>
  <?supplied-pmid 23934770?>
  <pub-id pub-id-type="pmid">23934770</pub-id>
 </mixed-citation>
</ref>
